6 unknown, 1 terminated. 3 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Terminated 1 |
| Phase 3 | 3 | Unknown 3 |
| Phase 1 | 2 | Unknown 2 |
Follow TQB2450 injection: new trials by email Literature Review of TQB2450 injection trials Research Report on TQB2450 injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors TQB2450 injection, AL2846 capsule, Pemetrexed disodium for injection - Solid Tumor | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 135 | 2022-09-02 | 2023-11-03 |
| Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. TQB2450 injection, Anlotinib Hydrochloride Capsule, Carboplatin Injection - Advanced Endometrial Cancer, Sarcoma of Uterus | Phase 2 | Terminated | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 71 | 2022-08-26 | 2026-01-09 |
| TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection TQB2450 injection, Anlotinib hydrochloride capsules - Hepatocellular Carcinoma, Adjuvant Therapy | Phase 2 | Unknown | Xianhai Mao | 37 | 2022-01-06 | 2022-05-04 |
| A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer Anlotinib Hydrochloride Capsules, Paclitaxel injection, TQB2450 injection - Recurrent Platinum-resistant Ovarian Cancer | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 405 | 2021-09-28 | 2021-12-08 |
| A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) TQB2450 injection, Anlotinib Hydrochloride Capsules, Pembrolizumab injection - Non Small Cell Lung Cancer | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 375 | 2021-08-06 | 2021-08-20 |
| A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer TQB2450 Injection, Anlotinib hydrochloride, Oxaliplatin injection - Advanced Biliary Cancer | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 392 | 2021-02-04 | 2021-03-22 |
| A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma TQB2450 injection, Anlotinib - Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 60 | 2019-04-23 | 2019-10-31 |
Carcinoma, Hepatocellular (2) · Carcinoma, Non-Small-Cell Lung (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (6) · Xianhai Mao (1)
China (7)